News and Press Releases Search About the CF Foundation Public Policy Cystic Fibrosis Foundation Therapeutics (CFFT) Research Advocacy Clinical Trials Drug Pipeline Genetic Therapies (-) CFTR Modulators 2019 (-) 2015 2014 2012 2011 (-) Press Releases About the CF Foundation | CFTR Modulators CF Foundation Celebrates FDA Approval of Orkambi as Important Advance for the CF Community Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation July 2, 2015 | 5 min read About the CF Foundation | CFTR Modulators Cystic Fibrosis Foundation Issues Statement on The New England Journal of Medicine Study on the Benefits of the Ivacaftor/Lumacaftor Combination Drug May 17, 2015 | 3 min read About the CF Foundation | CFTR Modulators | Research FDA Approves Ivacaftor for Children Ages 2 to 5 with Certain Rare CF Mutations March 18, 2015 | 3 min read